Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

75 ta ish

Ish: Exploring SLAMF5/CD84 in Cancer: Advancing the Frontiers of Tumor Immunology

  1. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

    Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi +3

    Sharh maqola20233 iqtibos
    ABI

  2. Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

    Oumayma Naji, Amina Ghouzlani, Soumaya Rafii +7

    Sharh maqola20242 iqtibos
    ABI

  3. Mechanisms of immune evasion in breast cancer

    Joshua P. Bates, Roshanak Derakhshandeh, Laundette P. Jones +1

    Sharh maqola20182 iqtibos
    ABI

  4. Seminars in Immunopathology

    Arya Biragyn, Maria Aliseychik, Е. И. Рогаев

    Boshqa20132 iqtibos
    ABI

  5. Cancer statistics, 2018

    Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal

    Maqola20182 iqtibos
    ABI

  6. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

    Joan Sayós, Chengbin Wu, M. Morra +11

    Maqola19982 iqtibos
    ABI

  7. SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

    Emily Chu, Jian Wu, Stacey S. Kang +1

    Sharh maqola20232 iqtibos
    ABI

  8. IRF8 directs stress-induced autophagy in macrophages and promotes clearance of Listeria monocytogenes

    Monica Gupta, Dong-Mi Shin, Lakshmi Ramakrishna +5

    Maqola20152 iqtibos
    ABI

  9. Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8

    Guoxing Wang, B.J. van Driel, Gongxian Liao +8

    Maqola20152 iqtibos
    ABI

  10. The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases

    Matthew A. Dragovich, Adam Mor

    Sharh maqola20182 iqtibos
    ABI

  11. Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages

    Xiaokang Zeng, Guangao Liu, Wanwen Peng +6

    Maqola20182 iqtibos
    ABI

  12. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer

    Yaping Zhang, Qun Zhang, Xingzhi Han +7

    Maqola20232 iqtibos
    ABI

  13. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders

    Dominik Kľoc, Slavomír Kurhajec, Mykhailo Huniadi +3

    Maqola20242 iqtibos
    ABI

  14. Homotypic Interactions Mediated by Slamf1 and Slamf6 Receptors Control NKT Cell Lineage Development

    Klaus Griewank, Christine Borowski, Svend T. Rietdijk +6

    Maqola20072 iqtibos
    ABI

  15. Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors

    Ninghai Wang, Peter J. Halibozek, Burcu Yigit +5

    Maqola20152 iqtibos
    ABI

  16. Identification of CD84 as a potent survival factor in acute myeloid leukemia

    Ying‐Hui Zhu, Mariam Murtadha, Miaomiao Liu +25

    Maqola20252 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI